Related Experiment Video
Updated: May 26, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes
Markus Heine1, Peter Nollau, Christoph Masslo
1Institute of Anatomy and Experimental Morphology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. ma.heine@uke.uni-hamburg.de
Abstract:
Members of the carcinoembryonic antigen cell adhesion molecules (CEACAMs) family are the prototype of tumour markers. Classically they are used as serum markers, however, CEACAMs could serve as targets for molecular imaging as well.In order to test the anti CEACAM monoclonal antibody T84.1 for imaging purposes, CEACAM expression was analysed using this antibody. Twelve human cancer cell lines from different entities were screened for their CEACAM expression using qPCR, Western Blot and FACS analysis. In addition, CEACAM expression was analyzed in primary tumour xenografts of these cells. Nine of 12 tumour cell lines expressed CEACAM mRNA and protein when grown in vitro. Pancreatic and colon cancer cell lines showed the highest expression levels with good correlation of mRNA and protein level. However, when grown in vivo, the CEACAM expression was generally downregulated except for the melanoma cell lines. As the CEACAM expression showed pronounced expression in FemX-1 primary tumours, this model system was used for further experiments. As the accessibility of the antibody after i.v. application is critical for its use in molecular imaging, the binding of the T84.1 monoclonal antibody was assessed after i.v. injection into SCID mice harbouring a FemX-1 primary tumour. When applied i.v., the CEACAM specific T84.1 antibody bound to tumour cells in the vicinity of blood vessels. This binding pattern was particularly pronounced in the periphery of the tumour xenograft, however, some antibody binding was also observed in the central areas of the tumour around blood vessels. Still, a general penetration of the tumour by i.v. application of the anti CEACAM antibody could not be achieved despite homogenous CEACAM expression of all melanoma cells when analysed in tissue sections. This lack of penetration is probably due to the increased interstitial fluid pressure in tumours caused by the absence of functional lymphatic vessels.
Insights
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) show promise for molecular imaging. While the T84.1 antibody targets CEACAMs, its tumor penetration is limited in vivo due to high interstitial fluid pressure.
Area of Science:
- Oncology
- Molecular Imaging
- Biotechnology
Background:
- Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) are established tumor markers.
- CEACAMs present potential targets for molecular imaging applications.
- The anti-CEACAM monoclonal antibody T84.1 was investigated for imaging utility.
Purpose of the Study:
- To evaluate CEACAM expression in various human cancer cell lines and xenografts.
- To assess the potential of the T84.1 antibody for in vivo molecular imaging of CEACAM-expressing tumors.
- To investigate antibody penetration and binding within tumor tissues after intravenous administration.
Main Methods:
- Screening of 12 human cancer cell lines for CEACAM expression using qPCR, Western Blot, and FACS analysis.
- Analysis of CEACAM expression in vitro and in vivo tumor xenografts.
- Assessment of T84.1 antibody binding and tumor penetration in SCID mice bearing FemX-1 melanoma xenografts after intravenous injection.
Main Results:
- Nine of 12 cell lines expressed CEACAM mRNA and protein in vitro, with highest levels in pancreatic and colon cancers.
- CEACAM expression was generally downregulated in vivo, except in melanoma cell lines.
- The T84.1 antibody demonstrated binding to CEACAM-expressing tumor cells near blood vessels, particularly at the tumor periphery, but lacked significant penetration into central tumor areas.
Conclusions:
- CEACAMs are expressed in various cancer types, with potential for imaging, especially in melanoma.
- Intravenous administration of the T84.1 antibody shows limited tumor penetration, likely due to high interstitial fluid pressure and lack of functional lymphatic vessels.
- Further strategies are needed to enhance antibody accessibility for effective molecular imaging of CEACAM-expressing tumors.
More Related Videos
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

